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before exposure to atmospheric air or intermittent hypoxia (IH), in
the absence or presence of 10 ng/ml TNF-α (Biosource). The IH
protocol consisted of 64 cycles of 10-min hypoxia period (5% O2 and
5% CO2) followed by 5-min reoxygenation (21% O2 and 5% CO2), using
the BioSpherix OxyCycler C42 system (BioSpherix, Redfield, NY, USA).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay was used to assess cell viability. Cells exposed to
atmospheric air alone were considered to be 100% viable.
Total RNA from cells was extracted using Trizol reagent (Ambion
Inc.) according to the manufacturer's protocol. First-strand cDNA wasObstructive sleep apnea (OSA) is a prevalent disorder affecting at
least 9%–15% middle-aged adults, which is characterized by repetitive
cycles of hypoxia followed by reoxygenation termed intermittent
hypoxia (IH) [1]. Recently, there is growing epidemiologic and clinical
data showing excess of cardiovascular morbidity and mortality in OSA
subjects [2]. However, it remains unknown whether OSA contributes
directly to atherogenesis or merely serves as a modifier of other effects.
Fatty acid-binding proteins (FABPs) are a group of molecules
facilitating lipid transportationwithin cells. To date, at least nine subtypes
have been described [3], each named after the first tissue isolation or
identification: L (liver), I (intestinal), H (muscle andheart), A (adipocyte),
E (epidermal), I (ileal), B (brain),M (myelin) and T (testis). Among them,
A- and E-FABP have been suggested to play a role in atherosclerosis based
on knock-out mice models [4] and clinical studies [5,6]. Subjects with
severe OSA were also found to have elevated serum A-FABP levels [7],
suggesting a mediating role between OSA and atherosclerosis.
Systemic inflammation has been suggested as an intermediary
mechanistic pathway for OSA-related cardiometabolic sequelae [8].
Among inflammatory cytokines, TNF-α is a potent pro-atherogenic
factor to be increased in the serum of OSA subjects compared to obese
controls [9]. Thus the aim of the present study was to investigate the
effects of IH or/and TNF-α onA-/E-FABP expressions in endothelial cells.
Human abdominal aortic endothelial cells (HAAE) were obtained
from ATCC and passages 3–9 were used for the experiment. ConfluentBlock, Queen Mary Hospital,
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s of intermittent hypoxia onsynthesized from 1 μg of total RNA using an oligo (dT) primer and M-
MLV RT kit (Invitrogen), and then amplified in a final volume of 20 μl
using FastStart Taq DNA polymerase (Roche). The amplified products
were separated on 1.5% agarose gels and visualized by ethidium
bromide staining. The expression levels of A-/E-FABP mRNAs was
quantified after normalization with guanine nucleotide binding
protein), beta polypeptide 2-like 1 (GNB2L1) mRNA.
Cells were lysed in CelLytic M mammalian cell lysis/extraction
reagent (Sigma) supplemented with 1/100 (v/v) protease inhibitor
cocktail (Calbiochem). The cell lysate was centrifuged at 14,000 g for
15 min at 4 °C and protein concentration in the supernatant was
measured using BioRad protein assay. Total cell lysate (40 µg) was
separated by SDS-polyacrylamide gel, and then transferred to a
nitrocellulose membrane (Amersham Biosciences). After blocking in
phosphate buffered saline containing 0.1% (v/v) Tween and 5% (w/v)
driedmilk, theproteinexpression levelwasexaminedusinganti-A-FABP
goat polyclonal (1:200; Santa Cruz Bioechnology) and anti-E-FABP
rabbit polyclonal (1:2000; Biovender Laboratory Medicine Inc.) anti-
bodies. β-actin was used for the normalization of A-/E-FABP expression.
Membranes were then incubated with horseradish peroxidase-conju-
gated anti-mouse, anti-rabbit or anti-goat IgG (Dako) and analyzed by
chemiluminescence (Amersham). Densitometric analysis of bands was
performed with GeneTools (Syngene, Frederick, MD, USA) to determine
the respective protein expression levels.
Data were expressed as means±SEM from at least 4 independent
experiments. Data were analyzed by Student's t test using GraphPad
Prism 3.0 (GraphPad Software Inc, San Diego, CA, USA). A p-valueb0.05
was considered statistically significant.
Our results for cell viability indicated that there was no difference
between the control group and other treatment groups, indicating that
neither IH nor TNF-α affected cell proliferation in our experimental
model. IH alone significantly upregulated A-/E-FABP mRNA and protein
expression levels. TNF-α also induced a trend of increase, while aA-/E-FABP expression in human aortic endothelial cells, Int J Cardiol
Fig. 1.mRNA and protein expression levels after exposure to intermittent hypoxia (IH) and/or TNF-α in human aortic endothelial cells. IH alone significantly upregulated A-/E-FABP
mRNA levels (A–B) as well as protein levels (C–D), TNF-α alone induced a trend of increase, while significant difference could only be observed in E-FABP but not in A-FABP. The
combination of TNF-α with IH caused additive effect on elevation of A-/E-FABP mRNA levels with borderline significance (A–B), while no significant difference was observed in
protein levels although there was a trend of further increase (C–D). Data were expressed as means±SEM from at least 4 independent experiments in duplicate. *pb0.05 vs. control;
**pb0.01 vs. control; #0.05bpb0.06 vs. IH.
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While the combination of TNF-α and IH caused a marginally higher
elevation of A-/E-FABPmRNA levels compared to IH alone (p=0.056 for
A-FABP and p=0.055 for E-FABP respectively), no significances were
achieved at their protein levels (Fig. 1A–D).
There is accumulating evidence that OSA is associated with
cardiovascular risks, especially atherosclerosis. However, due to
high comorbid prevalence of other atherogenic risk factors, such as
obesity, aging, hypertension, diabetes, and hyperlipidemia, it remains
unclear whether OSA contributes directly to atherogenesis.
Atherosclerosis has been suggested to be an immunoimflammatory
disease involving multiple pathways and a plethora of cell types.
Endothelial cells and macrophages have been regarded as two active
partners involved in the initiation and progression of atherosclerosis.
Recently, two isoforms of FABP family, A- and E-FABP, have been
detected to play a significant role in atherosclerosis, thereby giving rise
to great interests and further exploration. Both circulating A- and E-
FABP levels have been found to be independently associated with
carotid atherosclerosis in clinical studies [5,6], and combined A- and E-
FABP deficiency could provide synergistic protective effect on athero-
sclerosis in apoE−/−mice [4]. To date, the atheroprotective effect of A-
FABP has been demonstrated to be predominantly related to its actions
in macrophage [10]. To our knowledge, this is the first study to detect
the co-expressionofA- andE-FABP in culturedhumanaortic endothelialPlease cite this article as: Han Q, et al, Effects of intermittent hypoxia on
(2010), doi:10.1016/j.ijcard.2010.04.027cells, which is the critical cellular component in the development of
atherosclerosis. We also found that IH could elevate A- and E-FABP
expression levels, and the presence of TNF-αmight partially potentiate
such effect. These data, together with previous clinical results showing
elevated serum A-FABP levels in otherwise healthy men with severe
OSA [7], imply that FABP may serve as a linkage between OSA and
atherosclerosis. Further studies will be necessary to address the initial
signaling events which occur in response to IH.
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